Table 3.
Age- and BMI-adjusted prevalence of osteoporosis and osteopenia among T2DM patients stratified by gender in 4 NHANES (2005–2006, 2007–2008, 2009–2010, and 2013–2014).
Prevalence | Survey cycle | ||||
---|---|---|---|---|---|
2005–2006 | 2007–2008 | 2009–2010 | 2013–2014 | P value for linear trend | |
Osteoporosis | |||||
Men | 0.02 (0–0.30) | 2.29 (0–4.87) | 1.31 (0–2.63) | 1.21 (0.42–2.00) | 0.14 |
Women | 3.95 (0–7.98) | 4.95 (1.67–8.23) | 3.19 (0.81–5.57) | 10.13 (6.06–14.21) | 0.08 |
Osteopenia | |||||
Men | 21.34 (14.34–28.34) | 22.44 (18.05–26.82) | 20.98 (14.68–27.28) | 27.14 (19.01–35.26) | 0.35 |
Women | 25.22 (18.82–31.62) | 31.13 (25.08–37.17) | 35.34 (27.52–43.15) | 35.42 (26.82–44.02) | 0.04 |